Durability of antiretroviral therapy regimens and determinants for change in HIV-1-infected patients in the TREAT Asia HIV Observational Database (TAHOD-LITE).,Antiviral Therapy

当前位置： X-MOL 学术 › Antivir. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Durability of antiretroviral therapy regimens and determinants for change in HIV-1-infected patients in the TREAT Asia HIV Observational Database (TAHOD-LITE).
Antiviral Therapy ( IF 1.3 ) Pub Date : 2017-9-22 , DOI: 10.3851/imp3194
Rosario Martinez-Vega ₁ , Nicole L De La Mata _{2,

3} , Nagalingeswaran Kumarasamy ₄ , Penh Sun Ly ₅ , Kinh Van Nguyen ₆ , Tuti P Merati ₇ , Thi Thanh Pham ₈ , Man Po Lee ₉ , Jun Yong Choi ₁₀ , Jeremy L Ross ₁₁ , Oon Tek Ng ₁

Affiliation

Department of Infectious Diseases, Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, Singapore.
The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
Present address: Sydney School of Public Health, Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia.
YRG CARE Medical Centre, VHS, Chennai, India.
National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
National Hospital for Tropical Diseases, Hanoi, Vietnam.
Faculty of Medicine, Udayana University & Sanglah Hospital, Bali, Indonesia.
Infectious Disease Department, Bach Mai Hospital, Hanoi, Vietnam.
Department of Medicine, Queen Elizabeth Hospital, Hong Kong SAR, China.
Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea.
TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.

The durability of first-line regimen is important to achieve long-term treatment success for the management of HIV infection. Our analysis describes the duration of sequential ART regimens and identifies the determinants leading to treatment change in HIV-positive patients initiating in Asia.

中文翻译：

在TREAT Asia HIV观察数据库（TAHOD-LITE）中，抗逆转录病毒疗法的持久性和决定受HIV-1感染的患者变化的决定因素。

一线治疗方案的持久性对于控制HIV感染取得长期治疗成功至关重要。我们的分析描述了连续抗逆转录病毒疗法的持续时间，并确定了导致在亚洲开始的HIV阳性患者治疗改变的决定因素。

更新日期：2020-08-21

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11